Neoadjuvant Treatment of Breast Cancer - Advances and Limitations

Por Fasching, Peter A., Gaß, Paul, Hein, Alexander
Publicado no Breast Care (Basel) (2016)

Biomarkers in Women's Cancers, Gynecology, and Obstetrics

Por Fasching, Peter A., Konecny, Gottfried E., Spurdle, Amanda B.
Publicado em 2014

Update on Anti-EGFR Therapy

Por Chua, Daniel, Fasching, Peter, Ma, Brigette, Thongprasert, Sumitra, Wirth, Lori
Publicado em 2009

Invasive Breast Cancer: Recognition of Molecular Subtypes

Por Strehl, Johanna D., Wachter, David L., Fasching, Peter A., Beckmann, Matthias W., Hartmann, Arndt
Publicado em 2011

The integrative epigenomic-transcriptomic landscape of ER positive breast cancer

Por Gao, Yang, Jones, Allison, Fasching, Peter A., Ruebner, Matthias, Beckmann, Matthias W., Widschwendter, Martin, Teschendorff, Andrew E.
Publicado no Clin Epigenetics (2015)

Erratum to: The integrative epigenomic-transcriptomic landscape of ER positive breast cancer

Por Gao, Yang, Jones, Allison, Fasching, Peter A., Ruebner, Matthias, Beckmann, Matthias W., Widschwendter, Martin, Teschendorff, Andrew E.
Publicado no Clin Epigenetics (2016)

Expression of Neuroendocrine Markers in Different Molecular Subtypes of Breast Carcinoma

Por Wachter, David L., Hartmann, Arndt, Beckmann, Matthias W., Fasching, Peter A., Hein, Alexander, Bayer, Christian M., Agaimy, Abbas
Publicado em 2014

The PI3K Pathway: Background and Treatment Approaches

Por Lux, Michael P., Fasching, Peter A., Schrauder, Michael G., Hein, Alexander, Jud, Sebastian M., Rauh, Claudia, Beckmann, Matthias W.
Publicado no Breast Care (Basel) (2016)

Inhibition of Adhesion, Proliferation, and Invasion of Primary Endometriosis and Endometrial Stromal and Ovarian Carcinoma Cells by a Nonhyaluronan Adhesion Barrier Gel

Por Renner, Stefan P., Strissel, Pamela L., Beckmann, Matthias W., Lermann, Johannes, Burghaus, Stefanie, Hackl, Janina, Fasching, Peter A., Strick, Reiner
Publicado no Biomed Res Int (2015)

DNA methylation outliers in normal breast tissue identify field defects that are enriched in cancer

Por Teschendorff, Andrew E, Gao, Yang, Jones, Allison, Ruebner, Matthias, Beckmann, Matthias W., Wachter, David L., Fasching, Peter A., Widschwendter, Martin
Publicado no Nat Commun (2016)

Cost-Benefit Analysis of Endocrine Therapy in the Adjuvant Setting for Postmenopausal Patients with Hormone Receptor-Positive Breast Cancer, Based on Survival Data and Future Price...

Por Lux, Michael P., Reichelt, Claudia, Karnon, Jon, Tänzer, Thorsten D., Radosavac, Dragan, Fasching, Peter A., Beckmann, Matthias W., Thiel, Falk C.
Publicado em 2011

Relevance of Health Economics in Breast Cancer Treatment – the View of Certified Breast Centres and Their Patients

Por Lux, Michael, Hildebrandt, Thomas, Beyer-Finkler, Elke, Bani, Mayada, Loehberg, Christian, Jud, Sebastian, Rauh, Claudia, Schrauder, Michael, Fasching, Peter, Beckmann, Matthias
Publicado em 2013

Are Certified Breast Centers Cost-Effective?

Por Beckmann, Matthias W., Bani, Mayada R., Loehberg, Christian R., Hildebrandt, Thomas, Schrauder, Michael G., Wagner, Stefanie, Fasching, Peter A., Lux, Michael Patrick
Publicado em 2009

Promoter hypermethylation of the tumor-suppressor genes ITIH5, DKK3, and RASSF1A as novel biomarkers for blood-based breast cancer screening

Por Kloten, Vera, Becker, Birte, Winner, Kirsten, Schrauder, Michael G, Fasching, Peter A, Anzeneder, Tobias, Veeck, Jürgen, Hartmann, Arndt, Knüchel, Ruth, Dahl, Edgar
Publicado em 2013

Prognostic impact of circulating tumor cells assessed with the CellSearch System™ and AdnaTest Breast™ in metastatic breast cancer patients: the DETECT study

Por Müller, Volkmar, Riethdorf, Sabine, Rack, Brigitte, Janni, Wolfgang, Fasching, Peter A, Solomayer, Erich, Aktas, Bahriye, Kasimir-Bauer, Sabine, Pantel, Klaus, Fehm, Tanja
Publicado em 2012

Correlation of histological and macroscopic findings in peritoneal endometriosis

Por Strehl, Johanna D, Hackl, Janina, Wachter, David L, Klingsiek, Peter, Burghaus, Stefanie, Renner, Stefan P, Fasching, Peter A, Hartmann, Arndt, Beckmann, Matthias W
Publicado em 2013

Prospective evaluation of serum tissue inhibitor of metalloproteinase 1 and carbonic anhydrase IX in correlation to circulating tumor cells in patients with metastatic breast cance...

Por Müller, Volkmar, Riethdorf, Sabine, Rack, Brigitte, Janni, Wolfgang, Fasching, Peter A, Solomayer, Erich, Aktas, Bahriye, Kasimir-Bauer, Sabine, Zeitz, Julia, Pantel, Klaus, Fehm, Tanja
Publicado em 2011

The ubiquitin-like molecule interferon-stimulated gene 15 (ISG15) is a potential prognostic marker in human breast cancer

Por Bektas, Nuran, Noetzel, Erik, Veeck, Jürgen, Press, Michael F, Kristiansen, Glen, Naami, Amjad, Hartmann, Arndt, Dimmler, Arno, Beckmann, Matthias W, Knüchel, Ruth, Fasching, Peter A, Dahl, Edgar
Publicado em 2008

AGR3 in Breast Cancer: Prognostic Impact and Suitable Serum-Based Biomarker for Early Cancer Detection

Por Garczyk, Stefan, von Stillfried, Saskia, Antonopoulos, Wiebke, Hartmann, Arndt, Schrauder, Michael G., Fasching, Peter A., Anzeneder, Tobias, Tannapfel, Andrea, Ergönenc, Yavuz, Knüchel, Ruth, Rose, Michael, Dahl, Edgar
Publicado no PLoS One (2015)

Knowledge and attitudes regarding medical research studies among patients with breast cancer and gynecological diseases

Por Lux, Michael P., Hildebrandt, Thomas, Knetzger, Sandra-Maria, Schrauder, Michael G., Jud, Sebastian M., Hein, Alexander, Rauh, Claudia, Fasching, Peter A., Beckmann, Matthias W., Thiel, Falk C.
Publicado no BMC Cancer (2015)